Items where authors include "Pilling, S"

Article

Brewer, A-J, Saunders, R, Fearon, P et al. (7 more authors) (2022) Antisocial Cognition as a Mediator of the Peer Influence Effect and Peer Selection Effect in Antisocial Adolescents. European Child and Adolescent Psychiatry, 31 (1). pp. 177-187. ISSN 1018-8827

Fonagy, P, Butler, S, Cottrell, D orcid.org/0000-0001-8674-0955 et al. (14 more authors) (2020) Multisystemic therapy versus management as usual in the treatment of adolescent antisocial behaviour (START): 5-year follow-up of a pragmatic, randomised controlled, superiority trial. The Lancet Psychiatry, 7 (5). pp. 420-430. ISSN 2215-0366

Freeman, J, Vernon, J orcid.org/0000-0002-0072-9294, Pilling, S et al. (7 more authors) (2020) Five-year Pan-European, longitudinal surveillance of Clostridium difficile ribotype prevalence and antimicrobial resistance: the extended ClosER study. European Journal of Clinical Microbiology & Infectious Diseases, 39 (1). pp. 169-177. ISSN 0934-9723

Constantinou, MP, Goodyer, IM, Eisler, I et al. (8 more authors) (2019) Changes in General and Specific Psychopathology Factors Over a Psychosocial Intervention. Journal of the American Academy of Child & Adolescent Psychiatry, 58 (8). pp. 776-786. ISSN 0890-8567

Freeman, J, Vernon, J, Pilling, S et al. (5 more authors) (2018) The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011–2014. Clinical Microbiology and Infection, 24 (7). pp. 724-731. ISSN 1198-743X

Fonagy, P, Butler, S, Cottrell, D orcid.org/0000-0001-8674-0955 et al. (12 more authors) (2018) Multisystemic therapy versus management as usual in the treatment of adolescent antisocial behaviour (START): A pragmatic, randomised controlled, superiority trial. The Lancet Psychiatry, 5 (2). pp. 119-133. ISSN 2215-0366

Freeman, J, Pilling, S, Vernon, J et al. (1 more author) (2017) In vitro activities of MCB3681 and 8 comparators against Clostridium difficile isolates with known ribotypes and diverse geographical spread. Antimicrobial Agents and Chemotherapy, 61 (3). e02077-16. ISSN 0066-4804